4Revalue

Our Core Services

Please let us know which kind of test you are offering or searching for. We will try to find the perfect match.

Acute inhalation toxicity test

(e.g. after OECD Test Guideline No. 403)

Acute dermal irritation/Corrosion

(e.g. after OECD Test Guideline No. 404)

In vivo eye irritation/Serious eye damage

(e.g. after OECD Test Guideline No. 405)

Skin sensitisation

(e.g. after OECD Test Guideline No. 406)

Repeated dose 28-day oral toxicity study in rodents

(e.g. after OECD Test Guideline No. 407)

Repeated dose 90-Day oral toxicity study in rodents

(e.g. after OECD Test Guideline No. 408)

Repeated dose 90-Day oral toxicity study in non-rodents

(e.g. after OECD Test Guideline No. 409)

Subacute Inhalation Toxicity: 28-day study

(e.g. after OECD Test Guideline No. 412)

Subchronic Inhalation Toxicity: 90-day study

(e.g. after OECD Test Guideline No. 413)

Prenatal developmental toxicity study

(e.g. after OECD Test Guideline No. 414)

Two-Generation reproduction toxicity

(e.g. after OECD Test Guideline No. 416)

Absorption, distribution, metabolism and excretion (ADME). Toxicokinetics/dynamics test

(e.g. after OECD Test Guideline No. 417)

Acute oral toxicity test

(e.g. after OECD Test Guideline No. 420)

Skin sensitisation – Local lymph node assay

(e.g. after OECD Test Guideline No. 429)

In vitro skin corrosion: Transcutaneous electrical resistance test method (TER)

(e.g. after OECD Test Guideline No. 430)

In vitro skin corrosion: Reconstructed human epidermis (RhE) test method

(e.g. after OECD Test Guideline No. 431)

Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants

(e.g. after OECD Test Guideline No. 437)

In vitro skin irritation: reconstructed human epidermis test method

(e.g. after OECD Test Guideline No. 439)

Extended one-generation reproductive toxicity study

(e.g. after OECD Test Guideline No. 443)

Chronic toxicity study

(e.g. after OECD Test Guideline No. 452)

Combined chronic toxicity/carcinogenicity studies

(e.g. after OECD Test Guideline No. 453)

Bacterial reverse mutation test

(e.g. after OECD Test Guideline No. 471)

In vitro mammalian chromosomal aberration test

(e.g. after OECD Test Guideline No. 473)

In vivo mammalian erythrocyte micronucleus test

(e.g. after OECD Test Guideline No. 474)

In vivo mammalian bone marrow chromosomal aberration test

(e.g. after OECD Test Guideline No. 475)

In vitro mammalian cell micornucleus test

(e.g. after OECD Test Guideline No. 487)

Transgenic rodent somatic and germ cell gene mutation assays

(e.g. after OECD Test Guideline No. 488)

In vivo mammalian alkline comet assay

(e.g. after OECD No. Test Guideline 489)

Others

By searching, reading through or downloading the files, you accept the terms and conditions of the Disclaimer and the Intellectual Property Rights notice.

Disclaimer and Intellectual Property Rights Notice

4ReValue GmbH endeavors to maintain a high level of transparency to provide prospective purchasers with a clear understanding of the value and scope of its studies. All content, including but not limited to information, documents, and data made available on the 4ReValue website or on third-party websites linked thereto, is protected by applicable intellectual property laws and other relevant legal provisions.

Any reproduction, distribution, transmission, or other form of use of such content without the prior written consent of 4ReValue GmbH and, where applicable, the respective rights holders, constitutes a potential infringement of intellectual property rights and is strictly prohibited.

4ReValue GmbH disclaims any and all liability for direct, indirect, incidental, or consequential damages arising out of or in connection with the use of information provided on its website or through linked third-party websites, including any documents issued by 4ReValue. Furthermore, 4ReValue GmbH makes no representations or warranties as to the accuracy, completeness, or reliability of the information contained on its website and expressly excludes liability for any discrepancies between the website content and scientific or official publications.

In the event of any inconsistency between the adopted version of a document and other publicly accessible versions, the adopted version shall prevail.

By accepting the terms of this notice, the user acknowledges that:

The disclosure of scientific data, studies, and other information by 4ReValue does not grant permission or a license to use, reproduce, or exploit the content in violation of any intellectual property or data exclusivity rights.
4ReValue is not responsible for the use of scientific data, studies, or other information by third parties, including supplementary information provided by applicants.
For materials subject to intellectual property or third-party rights, the user must comply with the applicable terms of use or obtain written permission for reproduction, distribution, or other uses from the rights holder.
4ReValue is not responsible for, nor will it be held liable for, any infringement of pre-existing rights or other violations related to the information, documents, and data made available on its website.
For security reasons, we only save your IP address to grant you access to our confidential data. Every month, all IP addresses are automatically removed from our database.